Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)

Completed

• Conditions: CIN

• Registration Number: NCT03791606
• Lead Sponsor: Kaiyang Lin

Brief Summary

A retrospective, observational study included all consecutively critically ill patients undergoing percutaneous coronary intervention(PCI) at intensive care unit (ICU) in Fujian Provincial Hospital from January 1st 2012 to December 31st 2018. The aim was to determine the incidence,risk factors,prophylactic strategy and outcomes of CI-AKI in critically ill patients undergoing PCI.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-01-01
• Primary Completion: 2018-12-31
• Study Completion: 2018-12-31
• Study First Submitted: 2018-12-31
• Study First Submitted QC: 2018-12-31
• Status Verified: 2019-01
• Study First Posted: 2019-01-02
• Last Update Submitted: 2019-01-20
• Last Update Posted: 2019-01-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 755

Inclusion Criteria

• Critically ill patients undergoing PCI at ICU

Exclusion Criteria

• pregnancy
• lactation
• end-stage renal disease (eGFR <15 mL/min/1.73 m2)
• long-term dialysis treatment
• intravascular administration of contrast medium within the last 7 or 3 days postoperatively

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CI-AKI	1 year	an absolute SCr increase ≥0.3 mg/dL or a relative increase in SCr ≥50% within 48 hours of contrast medium exposure

Secondary Outcome Measures

Name	Time	Method
in-hospital adverse events	1 year	congestive heart failure \[CHF\], bleeding, stroke, reinfarction, stent thrombosis, required renal replacement therapy, length of hospital stay, hospital costs, and mortality

Trial Locations

Locations (1)

Fujian Provincial; 🇨🇳 Fuzhou, Fujian, China